Since 2000, the medical technology firm has been developing and producing various systems that can be used to treat vascular diseases. Its portfolio of products includes vessel prostheses made from ePTFE and polyester. Coating technologies involving collagen and heparin reduce the risk of thrombosis.
The firm also supplies stents, stent prostheses and various insertion systems that are designed based on its experience of nitinol and catheter technologies.
In the field of tissue engineering, JOTEC offers a patch made from a micro-porous collagen matrix and collagen membrane (Matricart) that helps in the creation of autologous cartilage implants.
Thomas Bogenschütz (CEO)
|Year of foundation|
In vivo endothelialisation of vessel prostheses through coating with DNA aptameres as catcher molecules for endothelial progenitor cells (EPC).
P +49 7471 922-0
F +49 7471 922-100
info [at] jotec [dot] net